STAAR Surgical Releases Q4 and Full Year 2025 Financial Results

Published on March 5, 2026
LAKE FOREST Calif.—STAAR Surgical Company (NASDAQ: STAA), a global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses for vision correction, has announced financial results for the fourth quarter and fiscal year ended January 2, 2026. The company reported net sales of $57.8 million for the fourth quarter of 2025, up by 18.1 percent from $49.0 million in the prior-year quarter. For fiscal year 2025, net sales were $239.4 million compared with $313.9 million in the prior year, a decrease of 23.7 percent.
Continue reading on website
Other news

Kasperek Optical Acquires Exclusive U.S. Distributorship of Luxury Italian-Made Diva Eyewear

March 5, 2026
ROMULUS, Mich.—Kasperek Optical, a family-owned optical wholesale manufacturer and distributor, has announced it has entered an exclusive partnership with Ioves Spa to become the new sole U.S. distributor for its Diva Eyewear collection. The company said this collaboration brings Italian craftsmanship and luxury design directly to independent eyecare professionals across the United States. “This p

Kits Eyecare Reports Record Fourth Quarter and Full Year 2025 Results

March 5, 2026
VANCOUVER, British Columbia—Kits Eyecare Ltd. (TSX: KITS), a vertically integrated eyecare provider, has announced record financial results for the fourth quarter and full year ended December 31, 2025. For the full year 2025, the company advised that revenue increased 27.1 percent to a record $202.5 million, compared with $159.3 million in 2024. Gross profit increased 34.4 percent to $72.1 million